Citations (76)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (5)
Lianne J. Stevens, Joanne M. Donkers, Jeroen Dubbeld, Wouter H. J. Vaes, Catherijne A. J. Knibbe, Ian P. J. Alwayn & Evita van de Steeg. (2020) Towards human ex vivo organ perfusion models to elucidate drug pharmacokinetics in health and disease. Drug Metabolism Reviews 52:3, pages 438-454.
Read now
Read now
Kathrin I. Foerster & Jürgen Burhenne. (2020) Microdosing drugs: a versatile technique to detect and assess drug–drug interactions. Expert Opinion on Drug Metabolism & Toxicology 16:6, pages 447-448.
Read now
Read now
Gab-jin Park, Soo Hyeon Bae, Wan-Su Park, Seunghoon Han, Min-Ho Park, Seok-Ho Shin, Young G Shin & Dong-Seok Yim. (2017) Drug–drug interaction of microdose and regular-dose omeprazole with a CYP2C19 inhibitor and inducer. Drug Design, Development and Therapy 11, pages 1043-1053.
Read now
Read now
Tal Burt, Christy S. John, Jon L. Ruckle & Le T. Vuong. (2017) Phase-0/microdosing studies using PET, AMS, and LC-MS/MS: a range of study methodologies and conduct considerations. Accelerating development of novel pharmaceuticals through safe testing in humans – a practical guide. Expert Opinion on Drug Delivery 14:5, pages 657-672.
Read now
Read now
Pernille Svendsen, Tarec C. El-Galaly, Karen Dybkær, Martin Bøgsted, Maria B. Laursen, Alexander Schmitz, Paw Jensen & Hans E. Johnsen. (2016) The application of human phase 0 microdosing trials: A systematic review and perspectives. Leukemia & Lymphoma 57:6, pages 1281-1290.
Read now
Read now
Articles from other publishers (71)
Marzieh Daniali & Mohammad Abdollahi. 2024. Encyclopedia of Toxicology. Encyclopedia of Toxicology
489
494
.
Elizabeth W. Tucker, Camilo A. Ruiz-Bedoya, Filipa Mota, Clara Erice, John Kim, Patricia de Jesus, Ravindra Jahdav, Melissa Bahr, Kelly Flavahan, Xueyi Chen, Charles A. Peloquin, Joel S. Freundlich & Sanjay K. Jain. (2023) Linezolid does not improve bactericidal activity of rifampin-containing first-line regimens in animal models of TB meningitis. International Journal of Antimicrobial Agents, pages 107048.
Crossref
Crossref
Matthew Cuthbert, G. Gregory Haff, John J. McMahon, Martin Evans & Paul Comfort. (2023) Microdosing: A Conceptual Framework for use as Programming Strategy for Resistance Training in Team Sports. Strength & Conditioning Journal Publish Ahead of Print.
Crossref
Crossref
Lisa van der Heijden, Merel van Nuland, Jos Beijnen, Alwin Huitema & Thomas Dorlo. (2022) A naïve pooled data approach for extrapolation of Phase 0 microdose trials to therapeutic dosing regimens. Clinical and Translational Science 16:2, pages 258-268.
Crossref
Crossref
Jarrod Bailey. 2023. Nonhuman Primate Welfare. Nonhuman Primate Welfare
559
588
.
Filipa Mota, Camilo A. Ruiz-Bedoya, Elizabeth W. Tucker, Daniel P. Holt, Patricia De Jesus, Martin A. Lodge, Clara Erice, Xueyi Chen, Melissa Bahr, Kelly Flavahan, John Kim, Mary Katherine Brosnan, Alvaro A. Ordonez, Charles A. Peloquin, Robert F. Dannals & Sanjay K. Jain. (2022) Dynamic 18F-Pretomanid PET imaging in animal models of TB meningitis and human studies. Nature Communications 13:1.
Crossref
Crossref
Ravi Shankar P. Singh, Martin E. Dowty, Mikhail Salganik, Joanne I. Brodfuehrer, Gregory S. Walker, Raman Sharma, Jean S. Beebe & Spencer I. Danto. (2022)
A Phase 1 Study to Assess Mass Balance and Absolute Bioavailability of Zimlovisertib in Healthy Male Participants Using a
14
C‐Microtracer Approach
. Clinical Pharmacology in Drug Development 11:7, pages 815-825.
Crossref
Crossref
Olivier Schueller, Ed Skucas, Galit Regev, Iain Shaw, Nand Singh, Mitesh Sanghvi, Marie Croft, Lauren Lohmer, Anginelle Alabanza & Jeegar Patel. (2022)
Absolute Bioavailability, Mass Balance, and Metabolic Profiling Assessment of [
14
C]‐Belumosudil in Healthy Men: A Phase 1, Open‐Label, 2‐Part Study
. Clinical Pharmacology in Drug Development 11:7, pages 786-794.
Crossref
Crossref
Tal Burt, Ad F. Roffel, Oliver Langer, Kirsten Anderson & Joseph DiMasi. (2022) Strategic, feasibility, economic, and cultural aspects of phase 0 approaches. Clinical and Translational Science 15:6, pages 1355-1379.
Crossref
Crossref
Clive G. Wilson, Leon Aarons, Patrick Augustijns, Joachim Brouwers, Adam S. Darwich, Tom De Waal, Grzegorz Garbacz, Simone Hansmann, Dagmara Hoc, Anela Ivanova, Mirko Koziolek, Christos Reppas, Philipp Schick, Maria Vertzoni & J. Arturo García-Horsman. (2022) Integration of advanced methods and models to study drug absorption and related processes: An UNGAP perspective. European Journal of Pharmaceutical Sciences 172, pages 106100.
Crossref
Crossref
Zoe Oesterreicher, Sabine Eberl, Beatrix Wulkersdorfer, Peter Matzneller, Claudia Eder, Esther van Duijn, Wouter H. J. Vaes, Birgit Reiter, Thomas Stimpfl, Walter Jäger, Alina Nussbaumer-Proell, Daniela Marhofer, Peter Marhofer, Oliver Langer & Markus Zeitlinger. (2022) Microdosing as a Potential Tool to Enhance Clinical Development of Novel Antibiotics: A Tissue and Plasma PK Feasibility Study with Ciprofloxacin. Clinical Pharmacokinetics 61:5, pages 697-707.
Crossref
Crossref
Joseph P. O'Shea, Patrick Augustijns, Martin Brandl, David J. Brayden, Joachim Brouwers, Brendan T. Griffin, René Holm, Ann-Christin Jacobsen, Hans Lennernäs, Zahari Vinarov & Caitriona M. O'Driscoll. (2022) Best practices in current models mimicking drug permeability in the gastrointestinal tract - An UNGAP review. European Journal of Pharmaceutical Sciences 170, pages 106098.
Crossref
Crossref
Sanaz Katal, Liesl S. Eibschutz, Babak Saboury, Ali Gholamrezanezhad & Abass Alavi. (2022) Advantages and Applications of Total-Body PET Scanning. Diagnostics 12:2, pages 426.
Crossref
Crossref
Christine Huynh, Andrea Henrich, Daniel S. Strasser, Marie‐Laure Boof, Mohamed Al‐Ibrahim, Henriette E. Meyer Zu Schwabedissen, Jasper Dingemanse & Mike Ufer. (2021) A Multipurpose First‐in‐Human Study With the Novel CXCR7 Antagonist ACT‐1004‐1239 Using CXCL12 Plasma Concentrations as Target Engagement Biomarker. Clinical Pharmacology & Therapeutics 109:6, pages 1648-1659.
Crossref
Crossref
Ran Xue, Rong Li, Jianxin Wang, Weiping Tong & Jianyu Hao. (2021) Horizons on the Therapy of Biliary Tract Cancers: A State-of-the-art Review. Journal of Clinical and Translational Hepatology 000:000, pages 000-000.
Crossref
Crossref
Neil Parrott, Sandra Suarez-Sharp, Filippos Kesisoglou, Shriram M. Pathak, David Good, Christian Wagner, André Dallmann, James Mullin, Nikunjkumar Patel, Arian Emami Riedmaier, Amitava Mitra, Kimberly Raines, James Butler, Maziar Kakhi, Min Li, Yang Zhao, Eleftheria Tsakalozou, Talia Flanagan, Jennifer Dressman & Xavier Pepin. (2021) Best Practices in the Development and Validation of Physiologically Based Biopharmaceutics Modeling. A Workshop Summary Report. Journal of Pharmaceutical Sciences 110:2, pages 584-593.
Crossref
Crossref
Atsuko Tomaru, Kota Toshimoto, Wooin Lee, Keiko Ishigame & Yuichi Sugiyama. (2021) A Simple Decision Tree Suited for Identification of Early Oral Drug Candidates With Likely Pharmacokinetic Nonlinearity by Intestinal CYP3A Saturation. Journal of Pharmaceutical Sciences 110:1, pages 510-516.
Crossref
Crossref
Bappaditya Chatterjee, Pinaki Sengupta & Rakesh Kumar Tekade. 2021. Biopharmaceutics and Pharmacokinetics Considerations. Biopharmaceutics and Pharmacokinetics Considerations
195
277
.
Ilse M. Welleman, Mark W. H. Hoorens, Ben L. Feringa, Hendrikus H. Boersma & Wiktor Szymański. (2020) Photoresponsive molecular tools for emerging applications of light in medicine. Chemical Science 11:43, pages 11672-11691.
Crossref
Crossref
Tal Burt, Graeme Young, Wooin Lee, Hiroyuki Kusuhara, Oliver Langer, Malcolm Rowland & Yuichi Sugiyama. (2020) Phase 0/microdosing approaches: time for mainstream application in drug development?. Nature Reviews Drug Discovery 19:11, pages 801-818.
Crossref
Crossref
Ahizechukwu C. Eke, Adeniyi Olagunju, Brookie M. Best, Mark Mirochnick, Jeremiah D. Momper, Elaine Abrams, Martina Penazzato, Tim R. Cressey & Angela Colbers. (2020) Innovative Approaches for Pharmacology Studies in Pregnant and Lactating Women: A Viewpoint and Lessons from HIV. Clinical Pharmacokinetics 59:10, pages 1185-1194.
Crossref
Crossref
Briana K. Chen, Victor M. Luna, Christina T. LaGamma, Xiaoming Xu, Shi-Xian Deng, Raymond F. Suckow, Thomas B. Cooper, Abhishek Shah, Rebecca A. Brachman, Indira Mendez-David, Denis J. David, Alain M. Gardier, Donald W. Landry & Christine A. Denny. (2020) Sex-specific neurobiological actions of prophylactic (R,S)-ketamine, (2R,6R)-hydroxynorketamine, and (2S,6S)-hydroxynorketamine. Neuropsychopharmacology 45:9, pages 1545-1556.
Crossref
Crossref
Jeroen Roosendaal, Hilde Rosing & Jos H. Beijnen. (2020) Stable Isotopically Labeled Intravenous Microdose Pharmacokinetic Trials as a Tool to Assess Absolute Bioavailability: Feasibility and Paradigm to Apply for Protein Kinase Inhibitors in Oncology. Clinical Pharmacology in Drug Development 9:5, pages 552-559.
Crossref
Crossref
Xiaomin Wang, Jian Chen, Josephine Reyes, Simon Zhou, Maria Palmisano & Yan Li. (2019) A Phase 1, Open-Label Study in Healthy Subjects to Evaluate the Absolute Bioavailability of AG-221 by a Microtracer Approach. Oncology and Therapy 8:1, pages 91-102.
Crossref
Crossref
Jeroen Roosendaal, Hilde Rosing & Jos H. Beijnen. (2020) Combining Isotopic Tracer Techniques to Increase Efficiency of Clinical Pharmacokinetic Trials in Oncology. Drugs in R&D 20:2, pages 147-154.
Crossref
Crossref
Filipa Mota, Ravindra Jadhav, Camilo A. Ruiz-Bedoya, Alvaro A. Ordonez, Mariah H. Klunk, Joel S. Freundlich & Sanjay K. Jain. (2020)
Radiosynthesis and Biodistribution of
18
F-Linezolid in
Mycobacterium tuberculosis
-Infected Mice Using Positron Emission Tomography
. ACS Infectious Diseases 6:5, pages 916-921.
Crossref
Crossref
Alvaro A. Ordonez, Hechuan Wang, Gesham Magombedze, Camilo A. Ruiz-Bedoya, Shashikant Srivastava, Allen Chen, Elizabeth W. Tucker, Michael E. Urbanowski, Lisa Pieterse, E. Fabian Cardozo, Martin A. Lodge, Maunank R. Shah, Daniel P. Holt, William B. Mathews, Robert F. Dannals, Jogarao V. S. Gobburu, Charles A. Peloquin, Steven P. Rowe, Tawanda Gumbo, Vijay D. Ivaturi & Sanjay K. Jain. (2020) Dynamic imaging in patients with tuberculosis reveals heterogeneous drug exposures in pulmonary lesions. Nature Medicine 26:4, pages 529-534.
Crossref
Crossref
Merel van Nuland, Hilde Rosing, Alwin D. R. Huitema & Jos H. Beijnen. (2019) Predictive Value of Microdose Pharmacokinetics. Clinical Pharmacokinetics 58:10, pages 1221-1236.
Crossref
Crossref
Daniela Schneider, Angela Oskamp, Marcus Holschbach, Bernd Neumaier, Andreas Bauer & Dirk Bier. (2019) Relevance of In Vitro Metabolism Models to PET Radiotracer Development: Prediction of In Vivo Clearance in Rats from Microsomal Stability Data. Pharmaceuticals 12:2, pages 57.
Crossref
Crossref
Katherina Walz & Juan I. Young. 2019. Cellular and Animal Models in Human Genomics Research. Cellular and Animal Models in Human Genomics Research
191
197
.
Tal Burt & Robert D. Combes. 2019. The History of Alternative Test Methods in Toxicology. The History of Alternative Test Methods in Toxicology
229
240
.
Elizabeth W. Tucker, Beatriz Guglieri-Lopez, Alvaro A. Ordonez, Brittaney RitchieMariah H. KlunkRicha SharmaYong S. Chang, Julian Sanchez-BautistaSarah FreyMartin A. LodgeSteven P. RoweDaniel P. HoltJogarao V. S. GobburuCharles A. PeloquinWilliam B. Mathews, Robert F. Dannals, Carlos A. Pardo, Sujatha KannanVijay D. Ivaturi & Sanjay K. Jain. (2018)
Noninvasive
11
C-rifampin positron emission tomography reveals drug biodistribution in tuberculous meningitis
. Science Translational Medicine 10:470.
Crossref
Crossref
Tal BurtLe Thuy VuongElizabeth Baker, Graeme C. Young, A. Daniel McCartt, Mats Bergstrom, Yuichi Sugiyama & Robert Combes. (2018) Phase 0, Including Microdosing Approaches: Applying the Three Rs and Increasing the Efficiency of Human Drug Development. Alternatives to Laboratory Animals 46:6, pages 335-346.
Crossref
Crossref
Claire Ambery, Graeme Young, Teresa Fuller, Aili L. Lazaar, Adrian Pereira, Adam Hughes, David Ramsay, Frans van den Berg & Peter Daley‐Yates. (2018)
Pharmacokinetics, Excretion, and Mass Balance of [
14
C]‐Batefenterol Following a Single Microtracer Intravenous Dose (Concomitant to an Inhaled Dose) or Oral Dose of Batefenterol in Healthy Men
. Clinical Pharmacology in Drug Development 7:8, pages 901-910.
Crossref
Crossref
Liliana Anguiano-Robledo, Claudia C. Calzada-Mendoza, Cornelio Barrientos-Alvarado & María Elena Hernández-Campos. 2018. Reflections on Bioethics. Reflections on Bioethics.
Malek Okour, Geo Derimanov, Rodger Barnett, Esther Fernandez, Santiago Ferrer, Stephanie Gresham, Mohammad Hossain, Francisco-Javier Gamo, Gavin Koh, Adrian Pereira, Katie Rolfe, Deborah Wong, Graeme Young, Harshad Rami & John Haselden. (2018) A human microdose study of the antimalarial drug GSK3191607 in healthy volunteers. British Journal of Clinical Pharmacology 84:3, pages 482-489.
Crossref
Crossref
Lisa A. Kramer & Ray Greek. (2018) Human Stakeholders and the Use of Animals in Drug Development. Business and Society Review 123:1, pages 3-58.
Crossref
Crossref
Jens Atzrodt, Volker Derdau, William J. Kerr & Marc Reid. (2018) Deuterium- and Tritium-Labelled Compounds: Applications in the Life Sciences. Angewandte Chemie International Edition 57:7, pages 1758-1784.
Crossref
Crossref
Jens Atzrodt, Volker Derdau, William J. Kerr & Marc Reid. (2018) Deuterium- und tritiummarkierte Verbindungen: Anwendungen in den modernen Biowissenschaften. Angewandte Chemie 130:7, pages 1774-1802.
Crossref
Crossref
Lázara Martínez Muñoz. (2018) Non-Clinical Contribution to Clinical Trials during Lead Optimization Phase. Behavioral Sciences 8:1, pages 17.
Crossref
Crossref
Sandeep Sinha & Divya Vohora. 2018. Pharmaceutical Medicine and Translational Clinical Research. Pharmaceutical Medicine and Translational Clinical Research
19
32
.
L. van Andel, H. Rosing, Z. Zhang, L. Hughes, V. Kansra, M. Sanghvi, M. M. Tibben, A. Gebretensae, J. H. M. Schellens & J. H. Beijnen. (2017) Determination of the absolute oral bioavailability of niraparib by simultaneous administration of a 14C-microtracer and therapeutic dose in cancer patients. Cancer Chemotherapy and Pharmacology 81:1, pages 39-46.
Crossref
Crossref
Miriam G. Mooij, Esther van Duijn, Catherijne A. J. Knibbe, Karel Allegaert, Albert D. Windhorst, Joost van Rosmalen, N. Harry Hendrikse, Dick Tibboel, Wouter H. J. Vaes & Saskia N. de Wildt. (2017) Successful Use of [14C]Paracetamol Microdosing to Elucidate Developmental Changes in Drug Metabolism. Clinical Pharmacokinetics 56:10, pages 1185-1195.
Crossref
Crossref
T Burt, D MacLeod, K Lee, A Santoro, DK DeMasi, T Hawk, M Feinglos, M Rowland & RJ Noveck. (2017) Intra-Target Microdosing - A Novel Drug Development Approach: Proof of Concept, Safety, and Feasibility Study in Humans. Clinical and Translational Science 10:5, pages 351-359.
Crossref
Crossref
T Burt, RJ Noveck, DB MacLeod, AT Layton, M Rowland & G Lappin. (2017) Intra-Target Microdosing (ITM): A Novel Drug Development Approach Aimed at Enabling Safer and Earlier Translation of Biological Insights Into Human Testing. Clinical and Translational Science 10:5, pages 337-350.
Crossref
Crossref
Mats Bergstrom. (2017) The Use of Microdosing in the Development of Small Organic and Protein Therapeutics. Journal of Nuclear Medicine 58:8, pages 1188-1195.
Crossref
Crossref
Wan-Su Park, Gab-jin Park, Seunghoon Han, Sooho Ban, Moon-Young Park, San-ho Kim, Seon-Myung Kim, Yong-Chul Kim, Hyung Sik Kim, Young G. Shin & Dong-Seok Yim. (2017) Human microdosing and mice xenograft data of AGM-130 applied to estimate efficacious doses in patients. Cancer Chemotherapy and Pharmacology 80:2, pages 363-369.
Crossref
Crossref
Rajkumar Cheluvappa, Paul Scowen & Rajaraman Eri. (2017) Ethics of animal research in human disease remediation, its institutional teaching; and alternatives to animal experimentation. Pharmacology Research & Perspectives 5:4, pages e00332.
Crossref
Crossref
Ravi Rajagopalan, Lin Pan, Caralee Schaefer, John Nicholas, Sharlene Lim, Shawn Misialek, Sarah Stevens, Lisa Hooi, Natalia Aleskovski, Donald Ruhrmund, Karl Kossen, Lea Huang, Sophia Yap, Leonid Beigelman, Vladimir Serebryany, Jyanwei Liu, Srikonda Sastry, Scott Seiwert & Brad Buckman. (2017) Preclinical Characterization and Human Microdose Pharmacokinetics of ITMN-8187, a Nonmacrocyclic Inhibitor of the Hepatitis C Virus NS3 Protease. Antimicrobial Agents and Chemotherapy 61:1.
Crossref
Crossref
M.M. Hann, M.K. Bayliss & A.R. Leach. 2017. Comprehensive Medicinal Chemistry III. Comprehensive Medicinal Chemistry III
560
576
.
A.F. Roffel, S.P. van Marle, J.J. van Lier, J. Hartstra & E.-J. van Hoogdalem. (2016) An evaluation of human ADME and mass balance studies using regular or low doses of radiocarbon. Journal of Labelled Compounds and Radiopharmaceuticals 59:14, pages 619-626.
Crossref
Crossref
T Burt, K Yoshida, G Lappin, L Vuong, C John, SN de Wildt, Y Sugiyama & M Rowland. (2016) Microdosing and Other Phase 0 Clinical Trials: Facilitating Translation in Drug Development. Clinical and Translational Science 9:2, pages 74-88.
Crossref
Crossref
M Rowland. (2016) Microdosing of protein drugs. Clinical Pharmacology & Therapeutics 99:2, pages 150-152.
Crossref
Crossref
Sieto Bosgra, Maria L. H. Vlaming & Wouter H. J. Vaes. (2015) To Apply Microdosing or Not? Recommendations to Single Out Compounds with Non-Linear Pharmacokinetics. Clinical Pharmacokinetics 55:1, pages 1-15.
Crossref
Crossref
Graham Lappin. 2016. Clinical Pharmacology: Current Topics and Case Studies. Clinical Pharmacology: Current Topics and Case Studies
151
160
.
Graham Lappin. (2016) Approaches to intravenous clinical pharmacokinetics: Recent developments with isotopic microtracers. The Journal of Clinical Pharmacology 56:1, pages 11-23.
Crossref
Crossref
Tal Burt, Douglas C. Rouse, Kihak Lee, Huali Wu, Anita T. Layton, Thomas C. Hawk, Douglas H. Weitzel, Bennett B. Chin, Michael Cohen-Wolkowiez, Shein-Chung Chow & Robert J. Noveck. (2015) Intraarterial Microdosing: A Novel Drug Development Approach, Proof-of-Concept PET Study in Rats. Journal of Nuclear Medicine 56:11, pages 1793-1799.
Crossref
Crossref
Graham Lappin. (2015) The expanding utility of microdosing. Clinical Pharmacology in Drug Development 4:6, pages 401-406.
Crossref
Crossref
Long Yuan, Annik Bergeron, Jean-Nicholas Mess, Dafang Zhong & Qin C JiJim X Shen, Yue Zhao & Xiaohui (Sophia) Xu. 2015. Advanced LC-MS Applications in Bioanalysis. Advanced LC-MS Applications in Bioanalysis
210
224
.
Richard Novak, Kristina Hart & Richard A. Mathies. (2015) Single cell measurement of telomerase expression and splicing using microfluidic emulsion cultures. Nucleic Acids Research 43:16, pages e104-e104.
Crossref
Crossref
Vincent P. DeMarco, Alvaro A. Ordonez, Mariah Klunk, Brendan Prideaux, Hui Wang, Zhang Zhuo, Peter J. Tonge, Robert F. Dannals, Daniel P. Holt, Carlton K. K. Lee, Edward A. Weinstein, Véronique Dartois, Kelly E. Dooley & Sanjay K. Jain. (2015)
Determination of [
11
C]Rifampin Pharmacokinetics within Mycobacterium tuberculosis-Infected Mice by Using Dynamic Positron Emission Tomography Bioimaging
. Antimicrobial Agents and Chemotherapy 59:9, pages 5768-5774.
Crossref
Crossref
Shinji Yamashita, Makoto Kataoka, Yuki Suzaki, Hiromitsu Imai, Takuya Morimoto, Kyoichi Ohashi, Akihiro Inano, Kazutaka Togashi, Kuninori Mutaguchi & Yuichi Sugiyama. (2015) An Assessment of the Oral Bioavailability of Three Ca-Channel Blockers Using a Cassette-Microdose Study: A New Strategy for Streamlining Oral Drug Development. Journal of Pharmaceutical Sciences 104:9, pages 3154-3161.
Crossref
Crossref
MA Turner, MG Mooij, WHJ Vaes, AD Windhorst, NH Hendrikse, CAJ Knibbe, LT Kõrgvee, W Maruszak, G Grynkiewicz, RC Garner, D Tibboel, BK Park & SN de Wildt. (2015)
Pediatric microdose and microtracer studies using
14
C in Europe
. Clinical Pharmacology & Therapeutics 98:3, pages 234-237.
Crossref
Crossref
Colin R. Garner, Kevin B. Park, Neil S. French, Caroline Earnshaw, Alessandro Schipani, Andrew M. Selby, Lindsay Byrne, Sarah Siner, Francis P. Crawley, Wouter H. J. Vaes, Esther van Duijn, Rianne deLigt, Heili Varendi, Jane Lass, Grzegorz Grynkiewicz, Wioletta Maruszak & Mark A. Turner. (2015)
Observational infant exploratory [
14
C]-paracetamol pharmacokinetic microdose/therapeutic dose study with accelerator mass spectrometry bioanalysis
. British Journal of Clinical Pharmacology 80:1, pages 157-167.
Crossref
Crossref
Cecilia Karlsson. 2015. Principles of Translational Science in Medicine. Principles of Translational Science in Medicine
229
233
.
Claire Beaumont, Graeme C. Young, Tom Cavalier & Malcolm A. Young. (2014) Human absorption, distribution, metabolism and excretion properties of drug molecules: a plethora of approaches. British Journal of Clinical Pharmacology 78:6, pages 1185-1200.
Crossref
Crossref
Luz Romero & José Miguel Vela. 2014. In Vivo Models for Drug Discovery. In Vivo Models for Drug Discovery
59
90
.
C Oo & K L Duchin. (2014) Can CYP3A Activity Be Evaluated for Drug Interaction Using a Nanogram Dose of Probe Drug?. Clinical Pharmacology & Therapeutics 95:5, pages 489-489.
Crossref
Crossref
Anders Persson, Martin Berglund, Greger Thornell, G?ran Possnert & Mehran Salehpour. (2014) Stripline split-ring resonator with integrated optogalvanic sample cell. Laser Physics Letters 11:4, pages 045701.
Crossref
Crossref
Peter Gierschik. 2014. Handbuch Ethik und Recht der Forschung am Menschen. Handbuch Ethik und Recht der Forschung am Menschen
71
82
.
G. Lappin, M. J. Boyce, T. Matzow, S. Lociuro, M. Seymour & S. J. Warrington. (2013) A microdose study of 14C-AR-709 in healthy men: pharmacokinetics, absolute bioavailability and concentrations in key compartments of the lung. European Journal of Clinical Pharmacology 69:9, pages 1673-1682.
Crossref
Crossref